Lazard Asset Management LLC Acquires 4,135 Shares of agilon health, inc. (NYSE:AGL)

Lazard Asset Management LLC raised its holdings in agilon health, inc. (NYSE:AGLGet Rating) by 150.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,878 shares of the company’s stock after buying an additional 4,135 shares during the quarter. Lazard Asset Management LLC’s holdings in agilon health were worth $150,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Level Financial Advisors Inc. bought a new stake in shares of agilon health in the 2nd quarter worth about $25,000. First Horizon Advisors Inc. grew its holdings in shares of agilon health by 772.7% in the 1st quarter. First Horizon Advisors Inc. now owns 1,213 shares of the company’s stock worth $31,000 after purchasing an additional 1,074 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of agilon health in the 2nd quarter worth about $173,000. Bridgefront Capital LLC bought a new stake in shares of agilon health in the 1st quarter worth about $212,000. Finally, MetLife Investment Management LLC bought a new stake in shares of agilon health in the 1st quarter worth about $262,000.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the stock. Wells Fargo & Company lowered their target price on shares of agilon health from $28.00 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, November 15th. TheStreet downgraded shares of agilon health from a “c-” rating to a “d+” rating in a research report on Thursday, August 18th. Royal Bank of Canada started coverage on shares of agilon health in a research report on Wednesday, September 14th. They set an “outperform” rating and a $33.00 price target on the stock. Truist Financial reduced their price target on shares of agilon health from $33.00 to $29.00 and set a “buy” rating on the stock in a research report on Wednesday, September 7th. Finally, The Goldman Sachs Group reduced their price target on shares of agilon health from $38.00 to $34.00 and set a “buy” rating on the stock in a research report on Tuesday, November 15th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $29.14.

agilon health Stock Performance

agilon health stock opened at $16.04 on Tuesday. The company has a current ratio of 2.48, a quick ratio of 2.48 and a debt-to-equity ratio of 0.04. agilon health, inc. has a 1 year low of $14.36 and a 1 year high of $28.36. The company has a market cap of $6.61 billion, a PE ratio of -61.69 and a beta of 0.93. The company’s 50-day moving average is $21.24 and its two-hundred day moving average is $21.68.

Insider Buying and Selling at agilon health

In other agilon health news, insider Benjamin Kornitzer sold 8,094 shares of the company’s stock in a transaction dated Tuesday, October 4th. The shares were sold at an average price of $24.27, for a total transaction of $196,441.38. Following the transaction, the insider now directly owns 10,426 shares in the company, valued at approximately $253,039.02. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, insider Benjamin Kornitzer sold 8,094 shares of the stock in a transaction that occurred on Tuesday, October 4th. The shares were sold at an average price of $24.27, for a total value of $196,441.38. Following the sale, the insider now directly owns 10,426 shares in the company, valued at approximately $253,039.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Benjamin Shaker sold 29,548 shares of the stock in a transaction that occurred on Thursday, October 20th. The shares were sold at an average price of $20.37, for a total transaction of $601,892.76. Following the completion of the sale, the insider now owns 25,625 shares in the company, valued at $521,981.25. The disclosure for this sale can be found here. In the last three months, insiders have sold 67,320 shares of company stock worth $1,468,302. Company insiders own 3.30% of the company’s stock.

About agilon health

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.

Featured Stories

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.